Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized treatment modalities for patients with relapsed/refractory hematologic cancers.¹ As CAR-T therapy becomes more widely applied, toxic effects unique to CAR-T treatment are being identified that may potentially affect any organ or system.² We report a case of a cutaneous toxic reaction after CAR-T therapy.